Cognitive, Behavioral and Aging Effects of Pain Medication in Alcohol Users
NCT02945293 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2021-05-13
Summary
The purpose of this study is to examine the relationship between heavy alcohol use, pain, and response to pain medication in older adults.
Conditions
- Mild to Heavy Alcohol Consumption
Interventions
- OTHER
-
Oxycodone
This study is interventional. Participants are given a single, one time administration of medication 10mg of oxycodone and observed
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute on Aging (NIA)
collaborator NIH -
Seattle Institute for Biomedical and Clinical Research
collaborator OTHER - lead OTHER
Principal Investigators
-
Monique M. Cherrier, Ph.D. · University of Washington
Eligibility
- Min Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2019-10-01
- Completion
- 2021-09-01
Countries
- United States
Study Locations
More Related Trials
-
Naltrexone for Heavy Drinking in Young Adults
NCT00568958 ·Status: COMPLETED ·Phase: PHASE4
-
Oxytocin in Alcohol Use Disorder
NCT02711189 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
NCT01076283 ·Status: COMPLETED ·Phase: PHASE2
-
Sex Differences in Risk for Alcohol Abuse
NCT04543942 ·Status: COMPLETED ·Phase: NA
-
Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers
NCT01829516 ·Status: COMPLETED ·Phase: PHASE4
-
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
NCT01519063 ·Status: COMPLETED ·Phase: PHASE2
-
Managing Alcoholism in People Who Do Not Respond to Naltrexone
NCT00115037 ·Status: COMPLETED ·Phase: PHASE4
-
Naltrexone Effects on Alcohol Intake
NCT00254670 ·Status: COMPLETED ·Phase: NA
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Post-Treatment Effects of Naltrexone
NCT00006449 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
Medication Development in Alcoholism: Acamprosate Versus Naltrexone
NCT00656630 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
NCT00920829 ·Status: COMPLETED ·Phase: PHASE4
-
Hangover, Congeners, Sleep and Occupational Performance
NCT00247585 ·Status: COMPLETED ·Phase: PHASE2
-
Neural and Hormonal Influences on Sex Differences in Risk for AUD
NCT04929288 ·Status: RECRUITING ·Phase: NA
-
Addictions Neuroclinical Assessment (ANA)
NCT04946851 ·Status: ENROLLING_BY_INVITATION
-
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921 ·Status: RECRUITING
-
Endophenotype for Alcohol Misuse in Healthy Minority Populations
NCT00256451 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice
NCT06312657 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Antioxidant Replacement Therapy in Patients With Alcohol Abuse
NCT00936000 ·Status: COMPLETED ·Phase: PHASE2
-
Medication Development for Opioid and Alcohol Abuse
NCT03205423 ·Status: COMPLETED ·Phase: PHASE2
-
Neurobiology of Alcohol and Nicotine Co-Addiction
NCT03338933 ·Status: COMPLETED
-
Probenecid Administration for Alcohol Craving and Consumption
NCT07118618 ·Status: RECRUITING ·Phase: PHASE2